AFT PHARMACEUTICALS LIMITED revenue for the last year amounted to 179.10 M AUD, the most of which — 179.11 M AUD — came from its highest performing source at the moment, Pharmaceutical Intellectual Property, the year earlier bringing 146.61 M AUD. The greatest contribution to the revenue figure was made by Australia — last year it brought AFT PHARMACEUTICALS LIMITED 99.18 M AUD, and the year before that — 88.09 M AUD.